BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 29781107)

  • 1. Pristimerin targeting NF-κB pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells.
    Tu Y; Tan F; Zhou J; Pan J
    Cell Biochem Funct; 2018 Jun; 36(4):228-240. PubMed ID: 29781107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice.
    Tian F; Zhang C; Tian W; Jiang Y; Zhang X
    Oncol Rep; 2012 Jul; 28(1):232-40. PubMed ID: 22552693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
    Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual cyclin-dependent kinase 4/6 inhibition by PD-0332991 induces apoptosis and senescence in oesophageal squamous cell carcinoma cells.
    Chen L; Pan J
    Br J Pharmacol; 2017 Aug; 174(15):2427-2443. PubMed ID: 28444744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming Linsitinib intrinsic resistance through inhibition of nuclear factor-κB signaling in esophageal squamous cell carcinoma.
    Wu J; Chen K; Zhang F; Jin J; Zhang N; Li D; Ying L; Chen W; Yu H; Mao W; Su D
    Cancer Med; 2017 Jun; 6(6):1353-1361. PubMed ID: 28440057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serine protease HtrA1 inhibits cell proliferation, reduces invasion, and induces apoptosis in esophageal squamous cell carcinoma by blocking the nuclear factor-κB signaling pathway.
    Xia J; Wang F; Wang L; Fan Q
    Tumour Biol; 2013 Feb; 34(1):317-28. PubMed ID: 23079781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Curcumin promotes apoptosis of esophageal squamous carcinoma cell lines through inhibition of NF-kappaB signaling pathway].
    Tian F; Song M; Xu PR; Liu HT; Xue LX
    Ai Zheng; 2008 Jun; 27(6):566-70. PubMed ID: 18570726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-429 inhibits the proliferation and migration of esophageal squamous cell carcinoma cells by targeting RAB23 through the NF-κB pathway.
    Wang Y; Yu XJ; Zhou W; Chu YX
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1202-1210. PubMed ID: 32096149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression.
    Chen Y; Wang D; Peng H; Chen X; Han X; Yu J; Wang W; Liang L; Liu Z; Zheng Y; Hu J; Yang L; Li J; Zhou H; Cui X; Li F
    Mol Cancer; 2019 Jan; 18(1):1. PubMed ID: 30609930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pristimerin effectively inhibits the malignant phenotypes of uveal melanoma cells by targeting NF‑κB pathway.
    Zhang B; Zhang J; Pan J
    Int J Oncol; 2017 Sep; 51(3):887-898. PubMed ID: 28766683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
    Zhao Y; Wei L; Shao M; Huang X; Chang J; Zheng J; Chu J; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
    Gastroenterology; 2017 Nov; 153(5):1304-1319.e5. PubMed ID: 28780075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pristimerin exhibits in vitro and in vivo anticancer activities through inhibition of nuclear factor-кB signaling pathway in colorectal cancer cells.
    Yousef BA; Hassan HM; Zhang LY; Jiang ZZ
    Phytomedicine; 2018 Feb; 40():140-147. PubMed ID: 29496166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAPI-1 Exhibits Anti-tumor Efficacy in Human Esophageal Squamous Cell Carcinoma Cells via Suppression of NF-κB Signaling Pathway.
    Gao L; Li L; Zhang D; Qiu J; Qian J; Liu H
    Dig Dis Sci; 2024 Jan; 69(1):81-94. PubMed ID: 38007701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plantamajoside inhibits lipopolysaccharide-induced epithelial-mesenchymal transition through suppressing the NF-κB/IL-6 signaling in esophageal squamous cell carcinoma cells.
    Li X; Chen D; Li M; Gao X; Shi G; Zhao H
    Biomed Pharmacother; 2018 Jun; 102():1045-1051. PubMed ID: 29710521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effects of metformin are a result of inhibiting nuclear factor kappa B nuclear translocation in esophageal squamous cell carcinoma.
    Sekino N; Kano M; Matsumoto Y; Sakata H; Akutsu Y; Hanari N; Murakami K; Toyozumi T; Takahashi M; Otsuka R; Yokoyama M; Shiraishi T; Okada K; Hoshino I; Iida K; Akimoto AK; Matsubara H
    Cancer Sci; 2018 Apr; 109(4):1066-1074. PubMed ID: 29396886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A small interfering RNA targeting NF-κB p65 alone or combined with 5-FU inhibits growth of esophageal squamous cell carcinoma in nude mice.
    Tian F; Fan T; Jiang Y; Zhang X; Wang X
    Pathol Res Pract; 2012 Jan; 208(1):32-8. PubMed ID: 22186294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-kappaB with antimyeloma activity in vitro and in vivo.
    Tiedemann RE; Schmidt J; Keats JJ; Shi CX; Zhu YX; Palmer SE; Mao X; Schimmer AD; Stewart AK
    Blood; 2009 Apr; 113(17):4027-37. PubMed ID: 19096011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of nuclear factor-κB expression in esophageal squamous cell carcinoma: prognostic significance and sensitivity to treatment with 5-FU.
    Hatata T; Higaki K; Tatebe S; Shomori K; Ikeguchi M
    Dis Esophagus; 2012; 25(8):716-22. PubMed ID: 22292507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ING5 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through regulation of the Akt/NF-κB/MMP-9 signaling pathway.
    Zhang GJ; Zhao J; Jiang ML; Zhang LC
    Biochem Biophys Res Commun; 2018 Feb; 496(2):387-393. PubMed ID: 29326045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway.
    Fang J; Chu L; Li C; Chen Y; Hu F; Zhang X; Zhao H; Liu Z; Xu Q
    Oncol Rep; 2015 Jan; 33(1):494-502. PubMed ID: 25405520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.